RedHill Biopharma Ltd. RDHL
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.41$0.45
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -4.13M | -6.72M | -9.31M |
| Total Depreciation and Amortization | -- | -- | 168.00K | 268.50K | 369.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 1.30M | 2.55M | 2.93M |
| Change in Net Operating Assets | -- | -- | -622.00K | -542.50K | -463.00K |
| Cash from Operations | -- | -- | -3.29M | -4.45M | -6.47M |
| Capital Expenditure | -- | -- | -4.00K | -8.00K | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -4.00K | -8.00K | -12.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -189.00K | -300.00K | -411.00K |
| Issuance of Common Stock | -- | -- | 3.45M | 3.45M | 3.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -104.50K | 739.00K |
| Cash from Financing | -- | -- | 3.26M | 3.04M | 3.78M |
| Foreign Exchange rate Adjustments | -- | -- | 9.00K | 16.50K | 24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -1.73M | -1.73M | -1.73M |
| Net Change in Cash | -- | -- | -1.75M | -3.12M | -4.41M |